Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
The goal of this interventional study is to Measure the potential benefits of combined
administration of cerebrolysin and amantadine sulfate as an add-on therapy to the standard
management of patients admitted to the ICU with traumatic brain injury.